These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31740175)

  • 1. A review of network simulation models of hepatitis C virus and HIV among people who inject drugs.
    Bellerose M; Zhu L; Hagan LM; Thompson WW; Randall LM; Malyuta Y; Salomon JA; Linas BP
    Int J Drug Policy; 2021 Feb; 88():102580. PubMed ID: 31740175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of direct and indirect social and spatial ties in the diffusion of HIV and HCV among people who inject drugs: a cross-sectional community-based network analysis in New Delhi, India.
    Clipman SJ; Mehta SH; Srikrishnan AK; Zook KJ; Duggal P; Mohapatra S; Shanmugam S; Nandagopal P; Kumar MS; Ogburn E; Lucas GM; Latkin CA; Solomon SS
    Elife; 2021 Aug; 10():. PubMed ID: 34342266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
    Semá Baltazar C; Boothe M; Kellogg T; Ricardo P; Sathane I; Fazito E; Raymond HF; Temmerman M; Luchters S
    BMC Public Health; 2020 Jun; 20(1):851. PubMed ID: 32493347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.
    Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB;
    Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study.
    Zelenev A; Li J; Mazhnaya A; Basu S; Altice FL
    Lancet Infect Dis; 2018 Feb; 18(2):215-224. PubMed ID: 29153265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injection partnership characteristics and HCV status associations with syringe and equipment sharing among people who inject drugs.
    Mackesy-Amiti ME; Boodram B; Page K; Latkin C
    BMC Public Health; 2023 Jun; 23(1):1191. PubMed ID: 37340398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling the impact of HIV and HCV prevention and treatment interventions for people who inject drugs in Dar es Salaam, Tanzania.
    Fraser H; Stone J; Wisse E; Sambu V; Mfisi P; Duran IJ; Soriano MA; Walker JG; Makere N; Luhmann N; Kafura W; Nouvellet M; Ragi A; Mundia B; Vickerman P
    J Int AIDS Soc; 2021 Oct; 24(10):e25817. PubMed ID: 34661964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual and network factors associated with HCV treatment uptake among people who inject drugs.
    Falade-Nwulia O; Sacamano P; McCormick SD; Yang C; Kirk G; Thomas D; Sulkowski M; Latkin C; Mehta SH
    Int J Drug Policy; 2020 Apr; 78():102714. PubMed ID: 32135398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intelligent Network DisRuption Analysis (INDRA): A targeted strategy for efficient interruption of hepatitis C transmissions.
    Campo DS; Khudyakov Y
    Infect Genet Evol; 2018 Sep; 63():204-215. PubMed ID: 29860098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics associated with HIV and hepatitis C seroprevalence among sexual and injecting partners of HIV positive persons who inject drugs in Nairobi and coastal Kenya.
    Sambai BC; Kingston H; Monroe-Wise A; Mbogo L; Juma E; Ludwig-Barron N; Guthrie BL; Bukusi D; Chohan BH; Scott J; Bosire R; Dunbar M; Macharia P; Masyuko S; Sinkele W; Herbeck JT; Farquhar C
    BMC Infect Dis; 2022 Jan; 22(1):73. PubMed ID: 35062890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis.
    Solomon SS; McFall AM; Lucas GM; Srikrishnan AK; Kumar MS; Anand S; Quinn TC; Celentano DD; Mehta SH
    PLoS Med; 2017 Nov; 14(11):e1002460. PubMed ID: 29182638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling the impact of HIV and hepatitis C virus prevention and treatment interventions among people who inject drugs in Kenya.
    Stone J; Fraser H; Walker JG; Mafirakureva N; Mundia B; Cleland C; Bartilol K; Musyoki H; Waruiru W; Ragi A; Bhattacharjee P; Chhun N; Lizcano J; Akiyama MJ; Cherutich P; Wisse E; Kurth A; Luhmann N; Vickerman P
    AIDS; 2022 Dec; 36(15):2191-2201. PubMed ID: 36111533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial.
    Solomon SS; Quinn TC; Solomon S; McFall AM; Srikrishnan AK; Verma V; Kumar MS; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Thomas DL; Sachdeva KS; Lucas GM; Mehta SH
    J Hepatol; 2020 Jan; 72(1):67-74. PubMed ID: 31604081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.
    McFall AM; Solomon SS; Lucas GM; Celentano DD; Srikrishnan AK; Kumar MS; Mehta SH
    Addiction; 2017 Aug; 112(8):1480-1487. PubMed ID: 28317210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injecting network structure determines the most efficient strategy to achieve Hepatitis C elimination in people who inject drugs.
    Brown C; Siegele M; Wright M; Cook C; Parkes J; I Khakoo S; Sacks-Davis R; Buchanan RM
    J Viral Hepat; 2021 Sep; 28(9):1274-1283. PubMed ID: 34048117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis.
    Artenie A; Stone J; Fraser H; Stewart D; Arum C; Lim AG; McNaughton AL; Trickey A; Ward Z; Abramovitz D; Alary M; Astemborski J; Bruneau J; Clipman SJ; Coffin CS; Croxford S; DeBeck K; Emanuel E; Hayashi K; Hermez JG; Low-Beer D; Luhmann N; Macphail G; Maher L; Palmateer NE; Patel EU; Sacks-Davis R; Van Den Boom W; van Santen DK; Walker JG; Hickman M; Vickerman P;
    Lancet Gastroenterol Hepatol; 2023 Jun; 8(6):533-552. PubMed ID: 36996853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. People who inject drugs in Bangladesh - The untold burden!
    Khan SI; Reza MM; Crowe SM; Rahman M; Hellard M; Sarker MS; Chowdhury EI; Rana AKMM; Sacks-Davis R; Banu S; Ross AG
    Int J Infect Dis; 2019 Jun; 83():109-115. PubMed ID: 30928433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of a geospatially targeted community-based testing approach with respondent-driven sampling to identify people who inject drugs living with HIV and HCV in Patti and Gorakhpur, India.
    Loeb TA; McFall AM; Srikrishnan AK; Anand S; Vasudevan CK; Mehta SH; Solomon SS
    Drug Alcohol Depend; 2023 Jun; 247():109874. PubMed ID: 37087926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys.
    Handanagic S; Bozicevic I; Civljak M; Dominkovic Z; Sevic S; Barbaric J; Nemeth Blazic T; Dakovic Rode O; Begovac J
    Int J Drug Policy; 2016 Jun; 32():57-63. PubMed ID: 27160504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Routes of Potential Hepatitis C Virus Transmission among People Who Inject Drugs: Secondary Blood Exposures Related to Injection Drug Use.
    Goldshear JL; Simpson KA; Kral AH; Wenger LD; Bluthenthal RN
    Subst Use Misuse; 2021; 56(6):751-757. PubMed ID: 33769203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.